Methotrexate and emerging therapies

被引：19

作者：

Kremer, JM ^{[1
]}

机构：

[1] Albany Med Coll, Dept Med, Div Rheumatol, Albany, NY 12208 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 1998年 / 24卷 / 03期

关键词：

D O I：

10.1016/S0889-857X(05)70032-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

It is likely that all new therapeutic interventions will be used with methotrexate in combination therapy. These combinations may yield real therapeutic advances. The potential for end organ toxicity, opportunistic infection, and malignancy will need to be carefully monitored with long-term, meticulously conducted observational studies. Expense, ease of use, and perceived benefit-to-risk ratio will determine which new agents became most commonly prescribed with methotrexate.

引用

页码：651 / +

页数：9

共 23 条

[1] Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis - A multicenter, case-control study
Alarcon, GS
Kremer, JM
Macaluso, M
Weinblatt, ME
Cannon, GW
Palmer, WR
StClair, EW
Sundy, JS
Alexander, RW
Smith, GJW
Axiotis, CA
[J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (05) : 356 - +
[2] Molecular therapeutics - Methotrexate and its mechanism of action
Cronstein, BN
[J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (12): : 1951 - 1960
[3] FURST DE, 1990, J RHEUMATOL, V17, P1628
[4] Lymphoma in patients with rheumatoid arthritis: Association with the disease state or methotrexate treatment
Georgescu, L
Quinn, GC
Schwartzman, S
Paget, SA
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1997, 26 (06) : 794 - 804
[5] INCIDENCE OF CANCER AMONG PATIENTS WITH RHEUMATOID-ARTHRITIS
GRIDLEY, G
MCLAUGHLIN, JK
EKBOM, A
KLARESKOG, L
ADAMI, HO
HACKER, DG
HOOVER, R
FRAUMENI, JF
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (04): : 307 - 311
[6] Kremer JM, 1996, J RHEUMATOL, V23, P459
[7] Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis - A multicenter study with literature review
Kremer, JM
Alarcon, GS
Weinblatt, ME
Kaymakcian, MV
Macaluso, M
Cannon, GW
Palmer, WR
Sundy, JS
StClair, EW
Alexander, RW
Smith, GJW
Axiotis, CA
[J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (10): : 1829 - 1837
[8] LONG-TERM PROSPECTIVE-STUDY OF THE USE OF METHOTREXATE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - UPDATE AFTER A MEAN OF 90 MONTHS
KREMER, JM
PHELPS, CT
[J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (02): : 138 - 145
[9] METHOTREXATE FOR RHEUMATOID-ARTHRITIS - SUGGESTED GUIDELINES FOR MONITORING LIVER TOXICITY
KREMER, JM
ALARCON, GS
LIGHTFOOT, RW
WILLKENS, RF
FURST, DE
WILLIAMS, HJ
DENT, PB
WEINBLATT, ME
[J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (03): : 316 - 328
[10] THE SAFETY AND EFFICACY OF THE USE OF METHOTREXATE IN LONG-TERM THERAPY FOR RHEUMATOID-ARTHRITIS
KREMER, JM
LEE, JK
[J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (07): : 822 - 831

← 1 2 3 →